Identification of Prognostic Gene Biomarkers in Non-Small Cell Lung Cancer Progression by Integrated Bioinformatics Analysis
The progression of non-small cell lung cancer (NSCLC) is linked to epithelial-mesenchymal transition (EMT), a biologic process that enables tumor cells to acquire a migratory phenotype and resistance to chemo- and immunotherapies. Discovery of novel biomarkers in NSCLC progression is essential for i...
Guardado en:
Autores principales: | Panagiotis Giannos, Konstantinos S. Kechagias, Annamaria Gal |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0a0d46903ab54f1281b85c27de13981c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
GJA1 promotes hepatocellular carcinoma progression by mediating TGF-β-induced activation and the epithelial–mesenchymal transition of hepatic stellate cells
por: Niu Gengming, et al.
Publicado: (2021) -
CD73 Severed as a Potential Prognostic Marker and Promote Lung Cancer Cells Migration via Enhancing EMT Progression
por: Zhao-wei Gao, et al.
Publicado: (2021) -
Four long noncoding RNAs act as biomarkers in lung adenocarcinoma
por: Zhang Zhihui, et al.
Publicado: (2021) -
Conditioned Media of Adipose-Derived Stem Cells Suppresses Sidestream Cigarette Smoke Extract Induced Cell Death and Epithelial-Mesenchymal Transition in Lung Epithelial Cells
por: Tzu-Yin Chen, et al.
Publicado: (2021) -
GPR37 promotes the malignancy of lung adenocarcinoma via TGF-β/Smad pathway
por: Wang Jian, et al.
Publicado: (2020)